Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
-
Cronos Group (CRON) to Invest in U.S. Cannabis Company PharmaCann
-
Cronos Group (CRON) Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021
-
Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021
-
Canaccord Genuity Upgrades Cronos Group (CRON:CN) (CRON) to Hold
-
Canaccord Genuity Downgrades Cronos Group (CRON:CN) (CRON) to Sell
-
Green Growth to launch hostile bid for pot producer Aphria
-
Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$17 at Canaccord Genuity
-
Canaccord Genuity Upgrades Cronos Group (CRON) to Hold
-
Canaccord Genuity Downgrades Cronos Group (CRON) to Sell Following Q4 Earnings Report
-
MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada

